The CRO Leadership Awards

In cooperation with Life Science Leader, Nice Insight is pleased to announce the results of the first
annual CRO Leadership Awards.

Nice Insight combines surveying of thousands of industry executives with other key analyses to
serve both partnering groups and facilitate better overall outsourcing collaborations. Life Science
Leader developed the annual CRO Leadership Awards to honor top performers based on responses
and better serve pharmaceutical and biopharmaceutical executives in their CRO vetting process.

Leaders In Preclinical — Accessibility

SERVICE AREAS: Bioanalytical, Preclinical
	Charles River Laboratories International Inc "At Charles River, we invest continuously in our people and portfolio to ensure that we have the expertise as well as the products and services to support our clients’ drug development programs.  Our passion for scientific excellence is a strong foundation for client relationships, which plays a pivotal role in developing the flexible research platforms that are integral to delivering innovative health solutions.  We are pleased that the marketplace recognizes our commitment to clients with this award." James C. Foster — Chairman, President, and Chief Executive Officer
SERVICE AREAS: Bioanalytical, Preclinical
	Critical Path Services, LLC "Our clients appreciate our focus on meeting their needs. The regulated sciences is a complex industry and our clients have many demands with little room for error. As a company our chosen core values are passion for excellence, integrity in practice, and drive with flexibility. Our staff all strive to live this daily and find ways to keep our customers delighted with our work products." Julie Eble, PhD — CEO
SERVICE AREAS: Preclinical
	Optivia Biotechnology Inc. "We are honored to receive this award as a validation of Optivia’s scientific leadership in the rapidly growing transporter assay market. We are very pleased that our clients are satisfied with our services, and we will continue to provide them with more innovative, value-added transporter assay services and discovery solutions, supporting discovery and development of safer and more efficacious medicines." Yong Huang, Ph.D. — President and CEO